Topamax (topiramate): Label Change – Risk For Development of Cleft Lip and/or Cleft Palate in Newborns

Audience: Neurology, OB/GYN ISSUE: FDA notified healthcare professionals and patients of an increased risk of development of cleft lip and/or cleft palate (oral clefts) in infants born to women treated with Topamax (topiramate) during pregnancy….



No related posts.